Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Mark Fernandes
AddedMar 31, 2024
UpdatedMay 31, 2026
Mark Fernandes

Mark Fernandes

Board Member, Spectro Cloud

CrunchbaseLinkedIn

Mark Fernandes's Career

Spectro Cloud
Spectro Cloud

San Jose, CA, US

Board Member· Board
Runnable
Runnable

San Francisco, CA, US

Board Member· Board
Paro
Paro

Chicago, IL, US

Board Member· Board
Thismoment
Thismoment

San Francisco, CA, US

Board Member· Board
Yalo
Yalo

San Francisco, CA, US

Board Member· Board
Reify Health
Reify Health

Boston, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Mark Fernandes's Career

Spectro Cloud
Spectro Cloud
Series D$67.5M1722019San Jose, CA, US
Board Member· Board

Leadership at Spectro Cloud

Saad MalikSaad MalikCo-Founder
Gaurav ManglikGaurav ManglikBoard Member
Gautam JoshiGautam JoshiCo-Founder
Tenry FuTenry FuCo-Founder
Runnable
Runnable
Seed$13.4M302013San Francisco, CA, US
Board Member· Board

Leadership at Runnable

Yash KumarYash KumarFounder
Brian WilcoveBrian WilcoveBoard Member

Similar to Runnable

StatefulStatefulBerkeley, CA, USDeveloper Toolsest. 2020StatefulBerkeley, CA, US · est. 2020

Stateful: Enhancing developer happiness with a social, rewarding, and fun coding tool.

Seed · $5.7M9
CodeanywhereCodeanywhereSan Francisco, CA, USDevelopment Platformest. 2011CodeanywhereSan Francisco, CA, US · est. 2011

Codeanywhere, Inc.: A real-time collaborative platform for developers, offering software solutions in California.

Angel · $1M12
StackBlitzStackBlitzSan Francisco, CA, USDevelopment Tools, Softwareest. 2018StackBlitzSan Francisco, CA, US · est. 2018

StackBlitz: Integrated software provider offering comprehensive facilities for programmers.

Seed · $7.9M375
Snip2CodeSnip2CodeSan Francisco, CA, USDeveloper Tools, Softwareest. 2012Snip2CodeSan Francisco, CA, US · est. 2012

Snip2Code: Enhancing software development and efficiency through innovative tools and knowledge preservation.

Seed · $25k1
Paro
Paro
Series C$68.5M2532015Chicago, IL, US
Board Member· Board

Leadership at Paro

Clara SiegClara SiegBoard Member
Anita SamojednikAnita SamojednikCEO
Michael BurdickMichael BurdickCo-Founder
Eddie LouEddie LouBoard Member
Dan WywrotDan WywrotCo-Founder
Thismoment
Thismoment
Series D$52M1252008San Francisco, CA, US
Board Member· Board

Leadership at Thismoment

Vince BroadyVince BroadyCo-Founder
Scott BedardScott BedardCo-Founder
Ankarino LaraAnkarino LaraCEO
Timothy MayhewTimothy MayhewBoard Member
Eric JeckEric JeckBoard Member
Yalo
Yalo
Series C$113M3162015San Francisco, CA, US
Board Member· Board

Leadership at Yalo

Rashmi GopinathRashmi GopinathBoard Member
Javier MataJavier MataCo-Founder
Javier MalaJavier MalaCo-Founder
Reify Health
Reify Health
Series D$479.6M1k2012Boston, MA, US
Board Member· Board

Leadership at Reify Health

Joseph AbrahamsonJoseph AbrahamsonCo-Founder
Henry LiHenry LiCo-Founder
Ralph PassarellaRalph PassarellaCo-Founder
Michael LinMichael LinBoard Member
Neeraj AgrawalNeeraj AgrawalBoard Member

Similar to Reify Health

MedableMedablePalo Alto, CA, USClinical Researchest. 2015MedablePalo Alto, CA, US · est. 2015

Medable: Accelerating therapies with a global cloud platform for efficient clinical research.

Series D · $506.6M750
Faro HealthFaro HealthSan Diego, CA, USClinical Trials Softwareest. 2019Faro HealthSan Diego, CA, US · est. 2019

Faro Health: Streamlining clinical trials with our cloud-native platform.

Series A · $35M42
Clinical Research IOClinical Research IOBoston, MA, USClinical Trials Softwareest. 2016Clinical Research IOBoston, MA, US · est. 2016

Health tech firm, CRIO, revolutionizes clinical trials with integrated eSource and CTMS solutions.

Seed · $19M83
ClinCaptureClinCaptureSan Francisco, CA, USClinical Trial Softwareest. 2013ClinCaptureSan Francisco, CA, US · est. 2013

ClinCapture: Streamlining clinical trials with cost-effective, privacy-focused software solutions.

Seed · $1.5M26

Mark Fernandes's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Mark Fernandes

John ConnorsJohn ConnorsBoard Member · DataSphere TechnologiesMarvin A. Francois, CFAMarvin A. Francois, CFACo-Founder · OnekinMichael WayneMichael WayneBoard Member · Kin CommunityMark ForbisMark ForbisBoard Member · InvestorKeepHans TungHans TungBoard Member · BDGMichael ConnMichael ConnBoard Member · Fanatics